MyFinsight
Home
Blog
About
Cash and cash
equivalents
$23,024K
(281.13%↑ Y/Y)
Prepaid expenses and
other current assets
$2,006K
(2.87%↑ Y/Y)
Total current assets
$25,030K
(213.23%↑ Y/Y)
Property and equipment,
net
$482K
(-18.03%↓ Y/Y)
Right of use assets -
operating leases
$277K
(-23.48%↓ Y/Y)
Other long-term
prepaid assets
$25K
Total assets
$25,814K
(188.71%↑ Y/Y)
Total liabilities and
stockholders equity...
$25,814K
(188.71%↑ Y/Y)
Total stockholders'
equity (deficit)
$18,730K
(1037.91%↑ Y/Y)
Total liabilities
$7,084K
(-2.89%↓ Y/Y)
Accumulated deficit
-$76,754K
(-38.10%↓ Y/Y)
Additional paid-in capital
$95,481K
(82.08%↑ Y/Y)
Total current
liabilities
$3,762K
(5.64%↑ Y/Y)
Convertible note, net
$3,087K
Operating lease
liabilities, net of current...
$122K
(-34.05%↓ Y/Y)
Warrant liability,
non-current
$113K
Common stock, 0.0001
par value,...
$3K
(200.00%↑ Y/Y)
Accounts payable
$1,858K
(8.91%↑ Y/Y)
Accrued expenses
$1,359K
(3.74%↑ Y/Y)
Other current
liabilities
$545K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. (SER)
source: myfinsight.com